Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease

CLN2 disease is one of a group of lysosomal storage disorders called the neuronal ceroid lipofuscinoses (NCLs). The disease results from mutations in the TPP1 gene that cause an insufficiency or complete lack of the soluble lysosomal enzyme tripeptidyl peptidase-1 (TPP1). TPP1 is involved in lysosom...

Descripción completa

Detalles Bibliográficos
Autores principales: Whiting, Rebecca E.H., Jensen, Cheryl A., Pearce, Jacqueline W., Gillespie, Lauren E., Bristow, Daniel E., Katz, Martin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957944/
https://www.ncbi.nlm.nih.gov/pubmed/27039708
http://dx.doi.org/10.1016/j.exer.2016.03.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957944/
https://www.ncbi.nlm.nih.gov/pubmed/27039708
http://dx.doi.org/10.1016/j.exer.2016.03.023

Ejemplares similares